Hanmi Pharmaceutical., Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hanmi Pharmaceutical., Company Limited with three other
companies in this sector in South Korea:
Daewoong Company Limited
sales of 1.02 trillion Korean Won [US$902.34 million]
of which 114%
was Medicinal Manufacturing & Selling),
Daewoong Pharmaceutical Company Limited
(883.92 billion Korean Won [US$785.81 million]
of which 100%
was Medicine Manufacture&Sale), and
Dong-A Socio Holdings Co Ltd
(726.17 billion Korean Won [US$645.56 million]
of which 67%
Hanmi Pharmaceutical., Company Limited reported sales of 882.72 billion Korean Won (US$784.74 million)
December of 2016.
decrease of 33.0%
versus 2015, when the company's sales were 1.32 trillion Korean Won.
Contributing to the drop in overall sales was the 38.3% decline
in Medicine, from 1.11 trillion Korean Won to 681.84 billion Korean Won.
There were also decreases in sales in
Overseas Medicine (down 6.0% to 192.45 billion Korean Won)
However, these declines were partially offset by the increase in sales of
Raw Medicine (up 20.3% to 8.43 billion Korean Won)